Skip to main content

Coxiella burnetii Phase II IgM

$357.00
SKU:
IB05038
Bulk Pricing:
Buy in bulk and save
Adding to cart… The item has been added
Enzyme immunoassay (ELISA) for the determination of human IgM antibodies directed against Coxiella burnetii in phase 2 in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures.<br><br>
 
The Rickettsia Coxiella burnetii, a worldwide distributed pathogen, is responsible for the disease known as Q fever. The small gram-negative, obligate intracellular bacterium reproduces in the digestive system of ticks (Dermacentor marginatus) and placental trophoblasts. As a result tick faeces and afterbirths of infected mammals (particularly sheep) are highly infectious.<br><br>
 
ELISA test-systems are especially suited for the differential analysis of immunoglobulin classes directed against the virus.
Assay Description:
1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time
Catalog number:
IB05038
configuration:
96 Determinations, 12x8 removable strips
controls:
1 negative and 1 positive Control, ready to use
design:
Enzyme linked immunosorbent assay (ELISA) technique
FDA Status:
For research use only, not for use in diagnostic procedures
MSDS:

MSDS

notes:
The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
Protocol:

Protocol

Sample types:
Serum or plasma (EDTA, citrate, heparin)
Sample volume:
100 µL of properly pretreated and diluted (1:101) unknown / determination
standards:
1 cut-off standard, ready to use
Standard range:
A calculated cut-off value is used to interpret results of unknowns
storage:
2 - 8°C
sensitivity:
> 94%
Species:
Human
Products related:

Rf-Absorbent (20 mL)